Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Nimotop Treatment Report
What is Nimotop?

Nimotop® is a brand name of the drug nimodipine. It is indicated for patients with a subarachnoid hemorrhage to improve their neurological outcome by reducing the incidence and severity of ischemic (oxygen) deficits.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Other 1 0

Mouse over the table for more information

Stop Reasons

Why Patients Stopped Taking Nimotop (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
1 100% Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Nimotop

Duration See details about how long patients take this treatment ▼

Stopped Taking Nimotop

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 22, 2010.